Evidence map›Paper›PMID 41031033›Full record

ArticlebioRxiv : the preprint server for biology2025

Evaluation of Alphafold modeling for elucidation of nanobody-peptide epitope interactions.

Shivani Sachdev, Swarnali Roy, Shubhra Saha, Gengxiang Zhao, Rashmi Kumariya, Brendan A Creemer, Rui Yin, Brian G Pierce, Carole A Bewley, Ross W Cheloha

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Shivani SachdevLaboratory of Bioorganic Chemistry; National Institutes of Diabetes, Digestive, and Kidney Diseases; National Institutes of Health, USA.
Swarnali RoyLaboratory of Bioorganic Chemistry; National Institutes of Diabetes, Digestive, and Kidney Diseases; National Institutes of Health, USA.
Shubhra SahaLaboratory of Bioorganic Chemistry; National Institutes of Diabetes, Digestive, and Kidney Diseases; National Institutes of Health, USA.
Gengxiang ZhaoLaboratory of Bioorganic Chemistry; National Institutes of Diabetes, Digestive, and Kidney Diseases; National Institutes of Health, USA.
Rashmi KumariyaLaboratory of Bioorganic Chemistry; National Institutes of Diabetes, Digestive, and Kidney Diseases; National Institutes of Health, USA.
Brendan A CreemerLaboratory of Bioorganic Chemistry; National Institutes of Diabetes, Digestive, and Kidney Diseases; National Institutes of Health, USA.
Rui YinUniversity of Maryland Institute for Bioscience and Biotechnology Research, Rockville, Maryland, USA.
Brian G PierceUniversity of Maryland Institute for Bioscience and Biotechnology Research, Rockville, Maryland, USA.
Carole A BewleyLaboratory of Bioorganic Chemistry; National Institutes of Diabetes, Digestive, and Kidney Diseases; National Institutes of Health, USA.
Ross W ChelohaLaboratory of Bioorganic Chemistry; National Institutes of Diabetes, Digestive, and Kidney Diseases; National Institutes of Health, USA.

Funding

Inhibitors and Probes of HIV-1 Cell FusionZIADK032103 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI BEWLEY, CAROLE · 2009 to 2025
$12.5M
New tools from chemistry and antibodies to address receptor functionZIADK075157 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI CHELOHA, ROSS · 2021 to 2025
$6.6M
Development of new antibody-fusion inhibitor conjugates to block HIV infectionZIADK075184 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI CHELOHA, ROSS · 2024 to 2025
$2.1M
High resolution modeling and design of immune recognitionR35GM144083 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI Brian G. Pierce · 2022 to 2026
$1.6M
Intramural NIH HHS ZIA DK032103Intramural NIH HHS ZIA DK075157Intramural NIH HHS ZIA DK075184NIGMS NIH HHS R35 GM144083
6 · The paper itself

Abstract

Models of Ab-antigen complexes can be used to understand interaction mechanisms and for improving affinity. This study evaluates the use of the protein structure prediction algorithm AlphaFold (AF) for exploration of interactions between peptide epitope tags and the smallest functional antibody fragments, nanobodies (Nbs). Although past studies of AF for modeling antibody-target (antigen) interactions suggested modest algorithm performance, those were primarily focused on Ab-protein interactions, while the performance and utility of AF for Nb-peptide interactions, which are generally less complex due to smaller antigens, smaller binding domains, and fewer chains, is less clear. In this study we evaluated the performance of AF for predicting the structures of Nbs bound to experimentally validated, linear, short peptide epitopes (Nb-tag pairs). We expanded the pool of experimental data available for comparison through crystallization and structural determination of a previously reported Nb-tag complex (Nb127). Models of Nb-tag pair structures generated from AF were variable with respect to consistency with experimental data, with good performance in just over half (4 out of 6) of cases. Even among Nb-tag pairs successfully modeled in isolation, efforts to translate modeling to more complex contexts failed, suggesting an underappreciated role of the size and complexity of inputs in AF modeling success. Finally, the model of a Nb-tag pair with minimal previous characterization was used to guide the design of a peptide-electrophile conjugate that undergoes covalent crosslinking with Nb upon binding. These findings highlight the utility of minimized antibody and antigen structures to maximize insights from AF modeling.

Identifiers

PMID41031033
PMCPMC12478407

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.